Inborn Errors of Metabolism

First in vivo success of a gene therapy for the maple syrup urine disease

AA201701 – Development of AAV vector platform for R&D purposes

Pr. Marina Cavazzana & Federico Mingozzi

M201702 – Gene therapy of Maple Sirup Urine Disease (MSUD)

Manuel Schiff and Clément Pontoizeau